Coagulopathies and thrombosis: usual and unusual causes and associations, part VI

Giuseppe Lippi; Emmanuel J Favaloro

doi:10.1055/s-0032-1301409

Coagulopathies and thrombosis: usual and unusual causes and associations, part VI

Giuseppe Lippi, Emmanuel J Favaloro

Dentistry and Medical Sciences

Research output: Contribution to journal › Editorial

2 Citations (Scopus)

Original language	English
Pages (from-to)	125-128
Number of pages	4
Journal	Seminars in Thrombosis and Hemostasis
Volume	38
Issue number	2
DOIs	https://doi.org/10.1055/s-0032-1301409
Publication status	Published - Mar 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1055/s-0032-1301409

Cite this

@article{0fc28f3a07334b94bea2aeaef270e253,

title = "Coagulopathies and thrombosis: usual and unusual causes and associations, part VI",

keywords = "Acute Coronary Syndrome/diagnosis, Altitude, Blood Coagulation Disorders/etiology, Coffee/adverse effects, Factor Xa Inhibitors, Heparin/adverse effects, Humans, Lipoproteins/physiology, Lymphatic Diseases/etiology, Morpholines/metabolism, Myocardial Infarction/diagnosis, Platelet Aggregation Inhibitors/adverse effects, Rivaroxaban, Thiophenes/metabolism, Thrombocytopenia/chemically induced, Thrombosis/complications, Troponin/metabolism, Venous Thrombosis/etiology, von Willebrand Diseases/complications",

author = "Giuseppe Lippi and Favaloro, {Emmanuel J}",

year = "2012",

month = mar,

doi = "10.1055/s-0032-1301409",

language = "English",

volume = "38",

pages = "125--128",

journal = "Seminars in Thrombosis and Hemostasis",

issn = "0094-6176",

publisher = "Thieme Medical Publishers, Inc.",

number = "2",

}

TY - JOUR

T1 - Coagulopathies and thrombosis

T2 - usual and unusual causes and associations, part VI

AU - Lippi, Giuseppe

AU - Favaloro, Emmanuel J

PY - 2012/3

Y1 - 2012/3

KW - Acute Coronary Syndrome/diagnosis

KW - Altitude

KW - Blood Coagulation Disorders/etiology

KW - Coffee/adverse effects

KW - Factor Xa Inhibitors

KW - Heparin/adverse effects

KW - Humans

KW - Lipoproteins/physiology

KW - Lymphatic Diseases/etiology

KW - Morpholines/metabolism

KW - Myocardial Infarction/diagnosis

KW - Platelet Aggregation Inhibitors/adverse effects

KW - Rivaroxaban

KW - Thiophenes/metabolism

KW - Thrombocytopenia/chemically induced

KW - Thrombosis/complications

KW - Troponin/metabolism

KW - Venous Thrombosis/etiology

KW - von Willebrand Diseases/complications

U2 - 10.1055/s-0032-1301409

DO - 10.1055/s-0032-1301409

M3 - Editorial

C2 - 22422326

SN - 0094-6176

VL - 38

SP - 125

EP - 128

JO - Seminars in Thrombosis and Hemostasis

JF - Seminars in Thrombosis and Hemostasis

IS - 2

ER -